Lineage Cell Therapeutics, Inc., 10% Owner at OncoCyte Corp (OCX), sold 4,000,000 shares at $1.66 ($6.6M) on 2019-09-11, disclosed to the SEC on 2019-09-13.
Open-market sale of $6.6M OCX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.